Seres — NPR 3 2019-END.qxd

П е р е д о в а я 21. Boeters DM, Raza K, van der Helm-van Mil AHM. Which patients presenting with arthralgia eventually develop rheumatoid arthritis? The current state of the art. RMD Open. 2017;3(2):e000479. doi: 10.1136/rmdopen-2017-000479. eCollection 2017. 22. Deane KD, El-Gabalawy H. Pathogenesis and prevention of rheu- matic disease: focus on preclinical RA and SLE. Nat Rev Rheumatol. 2014;10:212-28. doi: 10.1038/nrrheum.2014.6 23. Watad A, Bridgewood C, Russell T, et al. The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science. Front Immunol. 2018;9:2668. doi: 10.3389/fimmu.2018.02668 24. Olsen NJ, Karp DR. Autoantibodies and SLE:

the threshold for disease. Nat Rev Rheumatol. 2014;10:181-6. doi: 10.1038/nrrheum.2013.184 25. Winthrop KL, Weinblatt ME, Crow MK, et al. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018. Ann Rheum Dis. 2019 Feb 2. pii: annrheumdis-2018-214280. doi: 10.1136/annrheumdis-2018-214280 26. Eder L, Haddad A, Rosen CF, et al. The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study. Arthritis Rheum. 2016;68(4):915-23. doi: 10.1002/art.39494 27. Aydin SZ, Castillo-Gallego C, Ash ZR, et al.

Ultrasonographic assessment of nail in psoriatic disease shows a link between ony- chopathy and distal interphalangeal joint extensor tendon enthe- sopathy. Dermatology . 2012;225(3):231-5. doi: 10.1159/000343607 28. Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017 Mar;76(3):377- 90. doi: 10.1016/j.jaad.2016.07.064 29. Eder L, Polachek A, Rosen CF, et al. The development of psoriatic arthritis in patients with psoriasis is preceded by a period of non- specific musculoskeletal symptoms: a prospective cohort study. Arthritis Rheum. 2017;69(3):622-9. doi: 10.1002/art.39973. Erratum in: Arthritis Rheum . 2019;71(4):625. doi:

10.1002/art.40887 30. Thorarensen SM, Lu N, Ogdie A, et al. Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis. Ann Rheum Dis. 2017;76:521-5. doi: 10.1136/annrheumdis-2016-209334 31. Van Mechelen M, Lories RJ. Microtrauma: no longer to be ignored in spondyloarthritis? Curr Opin Rheumatol. 2016;28:176- 80. doi: 10.1097/BOR.0000000000000254 32. FitzGerald O, Haroon M, Giles JT, Winchester R. Concepts of patho- genesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther. 2015;17:115. doi: 10.1186/s13075-015-0640-3 33. Stuart PE, Nair RP, Tsoi LC, et al.

Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differ- ences in their genetic architecture. Am J Hum Genet. 2015;97(6):816-36. doi: 10.1016/j.ajhg.2015.10.019 34. Aterido A, Canete JD, Tornero J, et al. Genetic variation at the gly- cosaminoglycan metabolism pathway contributes to the risk of psoriat- ic arthritis but not psoriasis. Ann Rheum Dis. 2019;78(3). pii: e214158. doi: 10.1136/annrheumdis-2018-214158. Epub 2018 Dec 14. 35. Feld J, Chandran V, Haroon N, et al. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nat Rev Rheumatol. 2018;14(6):363-71. doi: 10.1038/s41584-018-0006-8 36. Blauvelt A, Chiricozzi A.

The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis. Clin Rev Allergy Immunol. 2018;55(3):379-90. doi: 10.1007/s12016-018-8702-3 37. Sch ц n MP, Erpenbeck L. The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis. Front Immunol. 2018;9:1323. doi: 10.3389/fimmu.2018.01323 38. Mylle S, Grine L, Speeckaert R, et al. Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly. Am J Clin Dermatol. 2018;19(5):625-37. doi: 10.1007/s40257-018-0366-5 39. Mattozzi C, Salvi M, D’Epiro S, et al. Importance of regulatory T cells in the pathogenesis of psoriasis: review of the literature. Dermatology .

2013;227(2):134-45. doi: 10.1159/000353398 40. Насонов ЕЛ, Александрова ЕН, Авдеева АС, Рубцов ЮП. Т-регуляторные клетки при ревматоидном артрите. Научно- практическая ревматология. 2014;52(4):430-7 [Nasonov EL, Aleksandrova EN, Avdeeva AS, Rubtsov YuP. T regulatory cells in rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014;52(4):430-7 (In Russ.)]. doi: 10.14412/1995-4484-2014-430-437 41. Авдеева АС, Рубцов ЮП, Дыйканов ДТ, Насонов ЕЛ. Клини- ко-патогенетическое значение Foxp3+ регуляторных Т-клеток при ревматоидном артрите. Научно-практическая ревматоло- гия. 2016;54(4):442-55 [Avdeeva AS, Rubtsov YuP, Dyikanov DT, Nasonov EL.

The clinical and pathogenetic value of Foxp3+ T regu- latory cells in rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016;54(4):442- 55 (In Russ.)]. doi: 10.14412/1995-4484-2016-442-455 42. Pereira LMS, Gomes STM, Ishak R, Vallinoto ACR. Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis. Front Immunol. 2017;8:605. doi: 10.3389/fimmu.2017.00605 43. Scher JU, Littman DR, Abramson SB. Microbiome in inflamma- tory arthritis and human rheumatic diseases. Arthritis Rheum. 2016;68:35-45. doi: 10.1002/art.39259 44. Li WQ, Han JL, Chan AT, Qureshi AA.

Psoriasis, psoriatic arthritis and increased risk of incident Crohn’s disease in US women. Ann Rheum Dis. 2013;72:1200-5. doi: 10.1136/annrheumdis-2012-202143 45. Scher JU, Ubeda C, Artacho A, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheum. 2015;67(1):128-39. doi: 10.1002/art.38892 46. Авдеева АС. ИФН γ -индуцируемый белок 10 (IP-10) при ревма- тоидном артрите: обзор литературы и собственные данные. Научно-практическая ревматология. 2017;55(6):655-61 [Avdeeva AS. IFN- γ -induced protein 10 (IP-10) in rheumatoid arthritis:

literature review and the authors' own data. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2017;55(6):655- 661 (In Russ.)]. doi: 10.14412/1995-4484-2017-655-661 47. Abji F, Pollock RA, Liang K, et al. Brief report: CXCL10 is a possible biomarker for the development of psoriatic arthritis among patients with psoriasis. Arthritis Rheum. 2016;68:2911-6. doi: 10.1002/art.39800 48. Cretu D, Gao L, Liang K, et al. Differentiating psoriatic arthritis from psoriasis without psoriatic arthritis using novel serum bio- markers. Arthritis Care Res (Hoboken). 2018;70(3):454-61. doi: 10.1002/acr.23298 49. Cretu D, Liang K, Saraon P, et al.

Quantitative tandem mass-spec- trometry of skin tissue reveals putative psoriatic arthritis biomark- ers. Clin Proteomics. 2015;12(1):1. doi: 10.1186/1559-0275-12-1 50. Frasca L, Palazzo R, Chimenti MS, et al. Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA. Front Immunol. 2018;9:1936. doi: 10.3389/fimmu.2018.01936 51. Yuan Y, Qiu J, Lin ZT, et al. Identification of Novel Autoantibodies Associated With Psoriatic Arthritis. Arthritis Rheum. 2019;71(6):941-51. doi: 10.1002/art.40830 52. Gisondi P, Tinazzi I, El-Dalati G, et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy:

a hospital-based case-control study. Ann Rheum Dis. 2008;67:26- 30. doi: 10.1136/ard.2007.075101 53. Simon D, Faustini F, Kleyer A, et al. Analysis of periarticular bone changes in patients with cutaneous psoriasis without associated psoriatic arthritis. Ann Rheum Dis. 2016;75(4):660-6. doi: 10.1136/annrheumdis-2014-206347 54. Tinazzi I, McGonagle D, Biasi D, et al. Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis. J Rheumatol. 2011;38(12):2691-2. doi: 10.3899/jrheum.110505 55. Araujo EG, Englbrecht M, Hoepken S, et al. Effects of ustek- inumab versus tumor necrosis factor inhibition on enthesitis:

results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study. Semin Arthritis Rheum. 2019;48(4):632-7. doi: 10.1016/j.semarthrit.2018.05.011 56. Колтакова АД. Регистры псориатического артрита. Обзор литературы. Научно-практическая ревматология. 2019;57(2):210-7 [Koltakova AD. Registers of psoriatic arthritis. Literature review. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2019;57(2):210-7 (In Russ.)]. doi: 10.14412/1995-4484-2019-210-217 Научно-практическая ревматология. 2019;57(3):250–254 254